SCHEMBL8992046

SCHEMBL8992046

CO[C@H]1O[C@H](COCc2ccccc2)[C@@H](O[C@H]2O[C@H](COCc3ccccc3)[C@H](O)[C@H](OCc3ccccc3)[C@H]2OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1OCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SSTR1 P30872 1/20 0.58
SSTR2 P30874 1/20 0.58
SSTR4 P31391 1/20 0.58
SSTR3 P32745 1/20 0.58
SSTR5 P35346 1/20 0.58
GJB2 P29033 2/20 0.53
PTPN1 P18031 9/20 0.49
PTPN2 P17706 4/20 0.49
PTPN11 Q06124 2/20 0.47
NT5E P21589 1/20 0.46
CDC25B P30305 5/20 0.46
BCHE P06276 1/20 0.45
SLC6A2 P23975 1/20 0.45
PTPN6 P29350 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10607794 1.00 SSTR1 (0.58) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL8992050 1.00 SSTR1 (0.58) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL10608933 0.94 SSTR1 (0.57) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL10608936 0.94 SSTR1 (0.57) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL10605657 0.93 SSTR1 (0.58) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL10605652 0.93 SSTR1 (0.58) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL8336531 0.93 SSTR5 (0.58) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL13088352 0.93 SSTR5 (0.58) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL4587088 0.93 SSTR5 (0.58) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL8992036 0.93 SSTR5 (0.58) SSTR1SSTR2SSTR4SSTR3SSTR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5504078-A α-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1996-04-02 US disclosed
EP-0532668-B1 NOVEL ALPHA-GLUCOSIDASE INHIBITORS MERRELL DOW PHARMA (US) 1995-11-15 EP disclosed
EP-0345104-B1 Novel Alpha-glucosidase inhibitors MERRELL DOW PHARMA (US) 1995-11-02 EP disclosed
EP-0422975-B1 Alpha-glucosidase inhibitors MERRELL DOW PHARMA (US) 1994-07-27 EP disclosed
US-5157116-A Antidiabetic agents MERRELL DOW PHARMACEUTICALS INC. (US) 1992-10-20 US disclosed
US-5097023-A α-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1992-03-17 US disclosed
EP-0422975-A1 Alpha-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1991-04-17 EP disclosed
EP-0422307-A1 Novel alpha-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1991-04-17 EP disclosed
EP-0389723-A1 Novel alpha-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1990-10-03 EP disclosed
EP-0390674-A1 Novel alpha-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1990-10-03 EP disclosed
EP-0345104-A2 Novel Alpha-glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1989-12-06 EP disclosed
EP-0344383-A1 Novel alpha-Glucosidase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1989-12-06 EP disclosed